» Articles » PMID: 36456837

Cord Blood Derived NK Cells Activated in Counter with Tumor Cells

Overview
Date 2022 Dec 1
PMID 36456837
Authors
Affiliations
Soon will be listed here.
Abstract

NK cells are initially known for their ability to kill tumor cells with no prior sensitization. Production of mature and long lasting NK cells from Umbilical Cord Blood (UCB) by using cytokines could be a promising method for immunotherapy. NK cells were generated from cord blood cells using IL2, IL7, and IL15 cytokines and measured expression of CD57 and NKp46 markers. Afterward, their capacity in the elimination of malignant cells (Reh cell line) was evaluated by assessment of interferon-γ (as cytokine production sign) and CD107-a expression (as cytotoxic function symptom) using flow cytometry. Our results showed efficient NKp46 + , and CD57 + NK cells generated on day 14. Also, expression of CD107-a and IFN-γ following co-culture with Reh cell lines significantly increased in comparison to the control. Taken together, we have reported one of the best culture conditions for the generation of CD57 + NK cells with on feeder cells and showed appropriate capacity in counter reh cell lines as a target.

References
1.
Armant M, Delespesse G, Sarfati M . IL-2 and IL-7 but not IL-12 protect natural killer cells from death by apoptosis and up-regulate bcl-2 expression. Immunology. 1995; 85(2):331-7. PMC: 1383900. View

2.
Carrasco Y, Batista F . B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node. Immunity. 2007; 27(1):160-71. DOI: 10.1016/j.immuni.2007.06.007. View

3.
Denman C, Senyukov V, Somanchi S, Phatarpekar P, Kopp L, Johnson J . Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells. PLoS One. 2012; 7(1):e30264. PMC: 3261192. DOI: 10.1371/journal.pone.0030264. View

4.
Freud A, Zhao S, Wei S, Gitana G, Molina-Kirsch H, Atwater S . Expression of the activating receptor, NKp46 (CD335), in human natural killer and T-cell neoplasia. Am J Clin Pathol. 2013; 140(6):853-66. DOI: 10.1309/AJCPWGG69MCZOWMM. View

5.
Luevano M, Daryouzeh M, Alnabhan R, Querol S, Khakoo S, Madrigal A . The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation. Hum Immunol. 2012; 73(3):248-57. DOI: 10.1016/j.humimm.2011.12.015. View